Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the ...

Onconova Therapeutics Inc ( (TRAW) ) has released its Q3 earnings. Here is a breakdown of the information Onconova Therapeutics Inc presented ...

A generic pill has been shown to reduce hospitalisation rates in high-risk patients with early COVID-19, potentially offering a low-cost alternative to oral antivirals from Merck & Co and others ...

Antiviral drugs can be used to block the herpes virus’s ability to make copies of itself, bringing the infection under control faster. Most cases of oral herpes are caused by herpes simplex ...

For the antiviral drugs formally approved by the FDA ... in particular HSV infections, acyclovir and its oral prodrug, valaciclovir, and penciclovir and its oral prodrug, famciclovir, have ...

[Reuters] A new program to provide oral antiviral treatments for Covid ... countries involved will be able to immediately give antiviral drugs to patients most at risk if they develop Covid ...

Oral antivirals are highly anticipated because ... Any prescribed COVID-19 medication will be dispensed with overnight shipping or routing to a patient's local pharmacy. There will be on-demand ...

The results, published in The Journal of Controlled Release, may lead to a long-acting, refillable implant that delivers an HIV antiviral medication, Islatravir, into humans living with human ...

BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2024, ...